GLP-1 fusion proteins

Details GLP-1 fusion proteins GLP-1 fusion proteins

2007-09-18

2007-09-18

Wax, Robert A (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S308000, C530S362000

Reexamination Certificate

active

10433108

ABSTRACT:
The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.

REFERENCES:
patent: 5665863 (1997-09-01), Yeh
patent: 5766883 (1998-06-01), Balance et al.
patent: 5876966 (1999-03-01), Reed
patent: 5876969 (1999-03-01), Fleer et al.
patent: 6190909 (2001-02-01), Levinson et al.
patent: 6191102 (2001-02-01), DiMarchi et al.
patent: 6514500 (2003-02-01), Bridon et al.
patent: 7141547 (2006-11-01), Rosen et al.
patent: 7189690 (2007-03-01), Rosen et al.
patent: 0 413 622 (1991-02-01), None
patent: WO97/24445 (1997-07-01), None
patent: WO98/04718 (1998-02-01), None
patent: WO 00 69911 (2000-11-01), None
patent: WO 01/79258 (2001-10-01), None
patent: WO 01/79271 (2001-10-01), None
patent: WO 03 059934 (2003-07-01), None
patent: WO 03 060071 (2003-07-01), None
Baggio et al., “A Recombinant Human Glucagon-Like Peptide (GLP)-1-Albumin Protein (Albugon) . . . ,” Diabetes, vol. 53, Sep. 2004, pp. 2492-2500.
Knudsen, Lotte B, et al: “Potent Derivatives of Glucagon-Like Peptide-1 with Pharmacokinetic Properties Suitable for once Daily Administration.” Journal of Medicinal Chemistry, vol. 43, No. 9, May 4, 2000, pp. 1664-1669, XP002222050, ISSN: 0022-2623.
Paige, et al. “Prolonged Circulation of Recombinant Human Granulocyte-Colony Stimulating Factor by Covalent Linkage to Albumin Through a Heterobifunctional Polyethylene Glycol.” Pharmaceutical Research, vol. 12, No. 12, 1995, pp. 1883-1885.
Sytkowski, A., et al. “An Erythropoietin Fusion Protein Comprised of Identical Repeating Domains Exhibits Enhanced Biological Properties.” The Journal of Biological Chemistry, vol. 274, No. 35, Aug. 1999, pp. 24773-24778.

Affiliated with

Also associated with

Rating

GLP-1 fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GLP-1 fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GLP-1 fusion proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3777853